Literature DB >> 3038918

Increased beta 2-adrenoreceptor density in heart, kidney and lung of spontaneously hypertensive rats.

M C Michel, X L Wang, E Schlicker, M Göthert, J J Beckeringh, O E Brodde.   

Abstract

The development of beta-adrenoreceptor density and beta 1- and beta 2-adrenoreceptor distribution has been investigated in heart, kidney and lung of spontaneously hypertensive (SHR) and normotensive (WKY) rats by (-)125I-iodocyanopinolol binding at the age of 5-6, 9-10 and 19-21 weeks. At all ages beta-adrenoreceptor density was similar in hearts of both strains, while it was increased in kidney and lung of SHR compared to WKY. The beta 2-adrenoreceptor density was higher in all three tissues of SHR at all ages investigated. On the other hand, beta 1-adrenoreceptor density was decreased in heart, unchanged in lung and increased in kidney of SHR compared to WKY. Destruction of presynaptic nerve terminals by treatment of WKY with 6-hydroxydopamine produced a 24% loss of cardiac beta 2-adrenoreceptors, whereas the beta 1-adrenoreceptor density remained unchanged, suggesting that at least part of the cardiac beta 2-adrenoreceptor population is localized prejunctionally. It is suggested that beta 2-adrenoreceptors are involved in the development or maintenance of high blood pressure in SHR, possibly by facilitating noradrenaline release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038918     DOI: 10.1111/j.1474-8673.1987.tb00132.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  9 in total

1.  Receptor modification in the brains of spontaneously hypertensive and Wistar-Kyoto rats: regionally specific and selective increase in cerebellar beta 2-adrenoceptors.

Authors:  C R Jones; J M Palacios; D Hoyer; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

2.  Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.

Authors:  R E de Boer; M R Steegstra; P A Kroezen; J Smit; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.

Authors:  O E Brodde; M Khamssi; H R Zerkowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Membrane proteins of the myocytes in cardiac overload.

Authors:  P Mansier; B Chevalier; E Mayoux; D Charlemagne; L Ollivier; F Callens-el Amrani; B Swynghedauw
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

5.  Activation of beta 2-adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats.

Authors:  L C Rump; M J Schuster; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

6.  Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

Authors:  C Damase-Michel; G Bompart; G Durrieu; J L Montastruc; P Montastruc; J P Girolami
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

7.  Myocardial hypertrophy, cardiac beta-adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs.

Authors:  M Galinier; J M Sénard; P Valet; G Dréan; V Planat; A Arias; M A Tran; J L Montastruc
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

8.  Can [I]-Iodocyanopindolol Label β(3)-Adrenoceptors in Rat Urinary Bladder?

Authors:  Tim Schneider; Martin Christian Michel
Journal:  Front Pharmacol       Date:  2010-10-25       Impact factor: 5.810

Review 9.  Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle.

Authors:  Martin C Michel; Sergio Parra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-12       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.